WWW - Posts tagged Dcth at BloggingStocks

dcth posts

Analyst Calls: AA, BA, BLK, DCTH, EBAY, NBR, SBUX, STI, TWX ...

Posted Apr 22nd 2010 11:40AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Analyst Initiations

Analyst Upgrades

Citigroup upgraded Blackrock (BLK) to hold from sell and removed the stock from its Top Picks Live list as a sell. The firm upped its target for shares to $198 from $190.
Jesup & Lamont upgraded Starbucks (SBUX) to buy from hold following the company's Q2 results. The firm raised its target for shares to $32 from $25.
CLSA upgraded Nabors Industries (NBR) to outperform from underperform. The firm said the Q1 report was in-line with their estimate and they expect U.S. land drilling to continue to improve. The firm has a $24 price target on the stock.
Alcoa (AA) was upgraded to neutral from underweight at HSBC.
Boeing (BA) was upgraded to outperform from neutral at Credit Suisse.
Chipotle Mexican Grill (CMG) was upgraded to buy from hold at Jefferies.

Continue reading Analyst Calls: AA, BA, BLK, DCTH, EBAY, NBR, SBUX, STI, TWX ...

Delcath jumps 18% as its chemotherapy agent gets orphan drug status

Posted Aug 31st 2009 5:30PM by Melly Alazraki (RSS feed)
Filed under: Press Releases, Products and Services

Delcath Systems Inc. (NASDAQ: DCTH), which in pre-market trading shot up 48%, closed the trading session up 18% to close at $3.60 after the FDA granted its chemotherapy agent doxorubicin, used primarily for live cancer an orphan drug status. The Orphan Drug Act was created to encourage and promote research for therapies of rare conditions and diseases that affect less than 200,000 a year in the United States.

Continue reading Delcath jumps 18% as its chemotherapy agent gets orphan drug status